[go: up one dir, main page]

DK0505377T3 - Muscarinreceptorantagonister - Google Patents

Muscarinreceptorantagonister

Info

Publication number
DK0505377T3
DK0505377T3 DK90917074.8T DK90917074T DK0505377T3 DK 0505377 T3 DK0505377 T3 DK 0505377T3 DK 90917074 T DK90917074 T DK 90917074T DK 0505377 T3 DK0505377 T3 DK 0505377T3
Authority
DK
Denmark
Prior art keywords
pct
compounds
date jun
sec
derived
Prior art date
Application number
DK90917074.8T
Other languages
English (en)
Inventor
Alexander Roderick Mackenzie
Peter Cross
Original Assignee
Pfizer
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Pfizer Ltd filed Critical Pfizer
Application granted granted Critical
Publication of DK0505377T3 publication Critical patent/DK0505377T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
DK90917074.8T 1989-12-12 1990-11-28 Muscarinreceptorantagonister DK0505377T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928041A GB8928041D0 (en) 1989-12-12 1989-12-12 Muscarinic receptor antagonists

Publications (1)

Publication Number Publication Date
DK0505377T3 true DK0505377T3 (da) 1996-02-05

Family

ID=10667812

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90917074.8T DK0505377T3 (da) 1989-12-12 1990-11-28 Muscarinreceptorantagonister

Country Status (14)

Country Link
US (1) US5281601A (da)
EP (1) EP0505377B1 (da)
JP (1) JPH0684370B2 (da)
AT (1) ATE132488T1 (da)
CA (1) CA2067816C (da)
DE (1) DE69024663T2 (da)
DK (1) DK0505377T3 (da)
ES (1) ES2082013T3 (da)
FI (1) FI104719B (da)
GB (1) GB8928041D0 (da)
GR (1) GR3019036T3 (da)
IE (1) IE70733B1 (da)
PT (1) PT96143B (da)
WO (1) WO1991009015A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932594A (en) * 1988-11-01 1999-08-03 Pfizer, Inc. Muscarinic receptor antagonists
US6693202B1 (en) 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
HK1049004A1 (en) * 2000-01-20 2003-04-25 Eisai Co., Ltd. Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
BR0215801A (pt) 2002-07-08 2005-05-10 Ranbaxy Lab Ltd Derivados de 3,6-dissubstituìdos azabiciclo [3.1.0] hexano úteis como antagonistas de receptores muscarìnicos
DE60226906D1 (de) * 2002-07-31 2008-07-10 Ranbaxy Lab Ltd 3,6-disubstituierte azabicyclo ä3.1.0ühexanderivate, die sich als muscarinrezeptorantagonisten eignen
WO2004014363A1 (en) * 2002-08-09 2004-02-19 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonist
EP1534675B1 (en) * 2002-08-23 2009-02-25 Ranbaxy Laboratories, Ltd. Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists
TW200800953A (en) * 2002-10-30 2008-01-01 Theravance Inc Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
EP1572648B1 (en) * 2002-12-10 2008-07-09 Ranbaxy Laboratories, Ltd. 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
ATE386738T1 (de) * 2002-12-23 2008-03-15 Ranbaxy Lab Ltd Flavaxat-derivate als muscarin-rezeptor antagonisten
EP1583741A1 (en) * 2002-12-23 2005-10-12 Ranbaxy Laboratories, Limited 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
US7488748B2 (en) 2003-01-28 2009-02-10 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
US7517905B2 (en) * 2003-04-09 2009-04-14 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
AU2003223010A1 (en) 2003-04-10 2004-11-01 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
DE60313898T2 (de) * 2003-04-10 2008-01-17 Ranbaxy Laboratories, Ltd. Substituierte azabicyclo hexane derivate als muscarin rezeptor antagonisten
EA009387B1 (ru) * 2003-04-11 2007-12-28 Рэнбакси Лабораториз Лимитед Азабициклические производные в качестве антагонистов мускаринового рецептора
US7368463B2 (en) * 2003-07-11 2008-05-06 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
US7234991B2 (en) * 2004-05-10 2007-06-26 Firecode Ltd. Moving toy
ATE419246T1 (de) * 2004-06-16 2009-01-15 Ranbaxy Lab Ltd Als antagonisten des muscarinrezeptors geeignete xanthinderivate
WO2006018708A2 (en) * 2004-08-19 2006-02-23 Ranbaxy Laboratories Limited Pyrrolidine derivatives as muscarinic receptor antagonists
WO2006032994A2 (en) * 2004-09-24 2006-03-30 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
EP1797040A1 (en) * 2004-09-29 2007-06-20 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
US20100016400A1 (en) * 2004-11-19 2010-01-21 Naresh Kumar Azabicyclic muscarinic receptor antagonists
EP1828126A1 (en) * 2004-12-15 2007-09-05 Ranbaxy Laboratories Limited Acid addition salts of muscarinic receptor antagonists
WO2006117754A1 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
US20090010923A1 (en) * 2007-04-24 2009-01-08 University Of Maryland, Baltimore Treatment of cancer with anti-muscarinic receptor agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632403A (da) * 1962-05-17 1900-01-01
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
DE3835291A1 (de) * 1988-04-19 1989-11-02 Bayer Ag 1,3-disubstituierte pyrrolidine

Also Published As

Publication number Publication date
DE69024663T2 (de) 1996-05-15
CA2067816C (en) 1997-03-25
US5281601A (en) 1994-01-25
EP0505377B1 (en) 1996-01-03
ES2082013T3 (es) 1996-03-16
JPH05501555A (ja) 1993-03-25
WO1991009015A1 (en) 1991-06-27
IE904462A1 (en) 1991-06-19
CA2067816A1 (en) 1991-06-13
FI922344A0 (fi) 1992-05-22
FI104719B (fi) 2000-03-31
JPH0684370B2 (ja) 1994-10-26
DE69024663D1 (de) 1996-02-15
PT96143B (pt) 1997-05-28
ATE132488T1 (de) 1996-01-15
GB8928041D0 (en) 1990-02-14
GR3019036T3 (en) 1996-05-31
FI922344L (fi) 1992-05-22
EP0505377A1 (en) 1992-09-30
IE70733B1 (en) 1996-12-11
PT96143A (pt) 1991-09-30

Similar Documents

Publication Publication Date Title
DK0505377T3 (da) Muscarinreceptorantagonister
DK0487071T3 (da) Kondenserede heterocykliske forbindelser, deres fremstilling og anvendelse
YU29892A (sh) Postupak za stereoselektivno dobijanje supstituisanih piperidina
RO93855A (ro) Procedeu pentru prepararea de arilciclobutilalchilamina
DK0518558T3 (da) 1-methylcarbapenemderivater, deres fremstilling og deres anvendelse som antibiotika
CO4410319A1 (es) Derivados de fenetanolamina
KR920004394A (ko) 티에노디아제핀 이의 제조방법 및 paf-길항 활성을 지닌 약제학적 조성물로서의 이의 용도
ATE64373T1 (de) Muscarin-rezeptor-antagonisten.
PT96422A (pt) Processo para a preparacao de derivados de piperidina e de pirrolidina uteis como agentes anticolinergicos
KR910004609A (ko) 아미노케톤 유도체 및 그의 용도
ATA226688A (de) Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3474143D1 (en) (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamines, a process for their preparation and their use as medicaments
US6127379A (en) Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
EP0769496A4 (en) 2,3-DIHYDROBENZOFURAN DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
HUT40800A (en) Process for producing aromatic compounds
FI870934A0 (fi) Penem-derivat.
AR021751A1 (es) Compuestos monociclicos, composiciones farmaceuticas que los contienen y su uso como antagonistas de receptor nk2 de taquiquinina en el tratamiento depatologias donde hay liberacion de taquiquininas
Piergentili et al. Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2, 2-Diphenyl-[1, 3]-dioxolan-4-ylmethyl-dimethylamine
DK0429751T3 (da) Substituerede 3-aminosydnoniminer, fremgangsmåde til deres fremstilling og deres anvendelse
RU93005335A (ru) Антогонисты рецептора тахикинина, изохинолины и способ их получения
ZA868243B (en) Derivatives of 3-imino-pyridazine,process for obtaining them and pharmaceutical compositions containing them
NO983452L (no) FremgangsmÕter for Õ hemme muskuloaponeurotisk fibromatose (desmoide tumorer)
BRPI0706384A2 (pt) composto ou sais do mesmo, método para preparação do composto, e, uso do composto ou sais do mesmo
Cook I. THE MERCURIC ACETATE OXIDATION OF SUBSTITUTED PYRROLIDINES. II. THE REACTION OF DIMETHYL MALEATE WITH REPRESENTATIVE ENAMINES.
FR2390956A1 (fr) Derives substitues de la quinolizidine et de l'indolizidine, leur procede de preparation et agents therapeutiques contenant lesdits derives